US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

156.44

-0.3850-0.25%

Volume:4.28M

Turnover:676.02M

Market Cap:10.95B

PE:8.58

High:159.66

Open:158.75

Low:156.37

Close:156.82

52wk High:169.89

52wk Low:92.64

Shares:70.00M

Float Shares:70.00M

Volume Ratio:1.22

T/O Rate:6.11%

Dividend:0.56

Dividend Rate:0.36%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)

Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)

Alliance Healthcare Wins ALPS Tender for Mobile Inpatient Home Care Services

Bamboos Health Care revamps company secretary and authorised representative roles

Oneview Healthcare Lists Additional CDI Securities from Employee Incentive Scheme

Analysts Offer Insights on Healthcare Companies: Capricor Therapeutics (CAPR) and Helus Pharma (HELP)

Worldwide Healthcare Trust Updates Share Capital and Voting Rights

Chinese Drug Regulator Accepts Marketing Application of Humanwell Healthcare's Unit for Pregabalin Tablets

MT Newswires Live

Argenx to Highlight Autoimmune Pipeline at Key U.S. Healthcare Conferences

CICC Reaffirms Their Buy Rating on Shanghai Henlius Biotech, Inc. Class H (2696)

IHH Healthcare Provides Update on Indian High Court Order on Case Involving Indian Unit

MT Newswires Live

Sonic Healthcare Limited (SHL) Receives a Sell from Morgan Stanley

Insider Makes Bold Move With Fresh Sensus Healthcare Stock Buy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/XBI/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":156.435,"timestamp":1789145864864,"preClose":156.82,"halted":0,"volume":4279840,"delay":0,"changeRate":-0.002455043999489803,"floatShares":70000000,"shares":70000000,"eps":18.23,"marketStatus":"Trading","change":-0.385,"latestTime":"09-11 12:57:47 EDT","open":158.75,"high":159.6607,"low":156.37,"amount":676018146.9488,"amplitude":0.020984,"askPrice":156.45,"askSize":220,"bidPrice":156.41,"bidSize":150,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.82,"sharesOutstanding":63325000,"nav":159.388213,"aum":10738780848.695,"dividendRate":0.003609,"bidAskSpread":0.000341,"preHourTrading":{"tag":"盘前","latestPrice":158.23,"preClose":156.82,"latestTime":"09:29 EDT","volume":40501,"amount":6393566.4319400005,"timestamp":1789133399999,"change":1.41,"changeRate":0.008991,"amplitude":0.013009},"postHourTrading":{"tag":"盘后","latestPrice":156.6,"preClose":156.82,"latestTime":"19:58 EDT","volume":83781,"amount":13132833.9652,"timestamp":1789084712330,"change":-0.22,"changeRate":-0.001403,"amplitude":0.003061},"volumeRatio":1.218638,"impliedVol":0.3054,"impliedVolPercentile":0.4382},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":70000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.218638,"shares":70000000,"dividePrice":0.5646,"high":159.6607,"amplitude":0.020984,"preClose":156.82,"low":156.37,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.435,"committee":-0.189189,"eps":18.23,"divideRate":0.003609,"volume":4279840,"delay":0,"ttmEps":18.23,"open":158.75,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":164.38,"twentyDayClose":156.86,"sixtyDayClose":135.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664851217","title":"Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851217","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851217?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Ch","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354160/0/en/liquidia-corporation-to-participate-in-wells-fargo-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","BK4501","LU1267930490.SGD","LU0289960550.SGD","TFNS","BK4207","LU0708994859.HKD","LU1074936037.SGD","LU0868494617.USD","XLV","LU0072461881.USD","LU0211328371.USD","LU0320765489.SGD","LU0942090050.USD","LU0251142724.SGD","LU1814569148.SGD","LU1506573853.SGD","LU0310800965.SGD","BK4588","LU1267930573.SGD","WFC","LU0211327993.USD","KBWB","LU1267930227.SGD","LU0048573561.USD","LU0256863811.USD","LU1280957306.USD","LU0130517989.USD","LQDA","PGF","BK4559","XBI","IE00B19Z3581.USD","LU0128525689.USD","LU0477156953.USD","LU0175139822.USD","IYF","LU1894683348.USD","LU0980610538.SGD","LU2461242641.AUD","LABU","LU0070302665.USD","HCSG","IE0002270589.USD","FTXO","LU0052756011.USD","LU0310799852.SGD","LU0128525929.USD","LU0314106906.USD","LU0742534661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859516","title":"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859516?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:10","pubTimestamp":1788264606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viridian Therapeutics (VRDN), Teladoc (TDOC) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-teladoc-tdoc-and-protagonist-therapeutics-ptgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-teladoc-tdoc-and-protagonist-therapeutics-ptgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TDOC","BK4167","BK4504","LU0128526141.USD","BK4534","PTGX","BK4139","BK4137","XLV","LU1861559042.SGD","BK4548","LU0029874061.USD","LU1861558580.USD","BK4581","HCSG","BK4585","VRDN","LABU","BK4567","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885625","title":"Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885625","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885625?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026  -- Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, which will take place in Boston, September 8 – 10, 2026. During meetings, management will discuss its commercial products and its robust pipeline of clinical stage kidney disease programs. About Akebia TherapeuticsAkebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release. Akebia Therapeutics ContactMercedes Carrascomcarrasco@akebia.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354088/37519/en/akebia-therapeutics-to-conduct-investor-meetings-at-the-2026-wells-fargo-healthcare-conference-in-boston.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0029864427.USD","LU0980610538.SGD","LU1035773651.USD","LU0256863811.USD","LU0683600562.USD","LU1363072403.SGD","LU0742534661.SGD","IYF","HCSG","LU0267386448.USD","LU2361045086.USD","LU0128525689.USD","LU0971096721.USD","LU0310800379.SGD","AKBA","KBWB","LU0787776722.HKD","XLV","LU0868494708.USD","LU1668664300.SGD","BK4501","XBI","LU0208291251.USD","PGF","LU0149725797.USD","BK4588","LU1894683348.USD","LU0175139822.USD","FTXO","LU0130102774.USD","LU0251142724.SGD","LU0052756011.USD","LU0310800965.SGD","LU2361044865.SGD","LU1267930490.SGD","LU0048573561.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0640476718.USD","IE00B19Z3B42.SGD","LU0310799852.SGD","LU1506573853.SGD","LABU","TFNS","LU0162691827.USD","LU1069347547.HKD","BK4139","LU0154236417.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEMS","FBT","BK4588","TBXU","BK4137","LU0128526141.USD","MEDI","CNCR","SYNB","XBI","XLV","BK4505","LEGN","GNOM","BK4139","IBB","LFSC","IBBQ","LABU","LU0029874061.USD","BK4585","BK4581","HCSG","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664562148","title":"Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664562148","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664562148?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354046/0/en/metagenomi-therapeutics-inc-to-present-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU0256863811.USD","LU0310800965.SGD","LU0128525929.USD","FTXO","LU0971096721.USD","LU2236285917.USD","LU0208291251.USD","TFNS","IYF","LU0106831901.USD","LU0787776722.HKD","MGX","LU1363072403.SGD","LU0175139822.USD","IE000M9KFDE8.USD","LU1506573853.SGD","LU0029864427.USD","HCSG","LU0868494617.USD","LU1668664300.SGD","BK4559","XLV","LU0128525689.USD","LU0417517546.SGD","LU0477156953.USD","BK4539","LU0128526141.USD","LU0211328371.USD","LENZ","PGF","BK4007","LU2361044949.HKD","LU0130102774.USD","KBWB","LU0211327993.USD","LU0251142724.SGD","LU0314106906.USD","LU0149725797.USD","LU1267930490.SGD","LABU","LU0130517989.USD","LU0154236417.USD","LU2361044865.SGD","LU1074936037.SGD","BK4501","IE00B19Z3B42.SGD","LU0708994859.HKD","LU0072461881.USD","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485625","title":"Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485625","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485625?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"CORAL GABLES, Fla., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354047/0/en/relmada-therapeutics-to-participate-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","LU0175139822.USD","LU0320765489.SGD","LU1035773651.USD","LU1267930573.SGD","BK4539","LU0128525929.USD","LU1280957306.USD","IE00B19Z3B42.SGD","LU0256863811.USD","LU0868494708.USD","LU2461242641.AUD","LU2361045086.USD","BK4588","LU0742534661.SGD","LU0477156953.USD","LU1668664300.SGD","BK4137","LU0128526141.USD","IYF","LU0029864427.USD","IE00B19Z3581.USD","FTXO","LU0128525689.USD","LU0310799852.SGD","LU0052756011.USD","IE00B7SZLL34.SGD","LU0640476718.USD","LU0942090050.USD","LU0648001328.SGD","XBI","LU0162691827.USD","TFNS","PGF","LU2361044949.HKD","XLV","LENZ","IE0002270589.USD","LU0072461881.USD","KBWB","LU0149725797.USD","LU1267930490.SGD","LU0211327993.USD","BK4139","LU0314106906.USD","LU1894683264.USD","LABU","LU0154236417.USD","HCSG","LU1069347547.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664868855","title":"Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664868855","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664868855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with ser","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353946/0/en/parabilis-medicines-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACP","BK4581","XBI","LABU","BK4139","BK4137","COAL","BK4588","LU0128526141.USD","PBLS","XLV","BK4006","HCC","HCSG","BK4585","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485589","title":"Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485589","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485589?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CHAPEL HILL, N.C., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) announced today that Chris Giordano, President & Chief","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353934/12401/en/tenax-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LU0128526141.USD","BK4585","BK4007","XBI","XLV","BK4539","BK4139","BK4581","HCSG","BK4137","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664685804","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685804?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258644,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-procept-biorobotics-prct-invivyd-ivvd-and-alpha-tau-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-procept-biorobotics-prct-invivyd-ivvd-and-alpha-tau-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4082","PRCT","XBI","LABU","LU0128526141.USD","LU2324357040.USD","BK4588","BK4585","BK4139","LU0029874061.USD","BK4539","XLV","BK4581","IVVD","DRTS","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830282","title":"Alliance Healthcare Wins ALPS Tender for Mobile Inpatient Home Care Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830282?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:48","pubTimestamp":1788256126,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alliance Healthcare Group Ltd. ( ($SG:MIJ) ). Alliance Healthcare Group has secured a three-year tender from AL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-wins-alps-tender-for-mobile-inpatient-home-care-services?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-wins-alps-tender-for-mobile-inpatient-home-care-services?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","SG","BK4585","XBI","HBCP","BK4195","XLV","BK4581","HCSG","BK4137","BK4209","LU0029874061.USD","BK4588","LABU","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664283757","title":"Bamboos Health Care revamps company secretary and authorised representative roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2664283757","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664283757?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:11","pubTimestamp":1788253869,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has issued an announcement. Bamboos Health Care Holdings announced the resignation of company secre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-revamps-company-secretary-and-authorised-representative-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-revamps-company-secretary-and-authorised-representative-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4588","LABU","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832411","title":"Oneview Healthcare Lists Additional CDI Securities from Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832411?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:53","pubTimestamp":1788252800,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Oneview Healthcare Chess Depository Interests repr 1 ( ($AU:ONE) ). Oneview Healthcare plc has applied for the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-lists-additional-cdi-securities-from-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-lists-additional-cdi-securities-from-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","BK4588","XBI","LABU","LU0029874061.USD","HCSG","BK4137","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664583470","title":"Analysts Offer Insights on Healthcare Companies: Capricor Therapeutics (CAPR) and Helus Pharma (HELP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664583470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664583470?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Capricor Therapeutics (CAPR) and Helus Pharma (HELP)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-capricor-therapeutics-capr-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-capricor-therapeutics-capr-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","XLV","BK4588","CAPR","LU0128526141.USD","BK4137","HCSG","HELP","LU0029874061.USD","XBI","LABU","BK4581","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664283635","title":"Worldwide Healthcare Trust Updates Share Capital and Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2664283635","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664283635?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:27","pubTimestamp":1788244038,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) has shared an update. Worldwide Healthcare Trust PLC has reported its latest share capital and vot...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-updates-share-capital-and-voting-rights-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-updates-share-capital-and-voting-rights-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XBI","LU0128526141.USD","BK4585","LABU","XLV","BK4137","BK4588","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336068","title":"Chinese Drug Regulator Accepts Marketing Application of Humanwell Healthcare's Unit for Pregabalin Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336068","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664336068?lang=en_us&edition=fundamental","pubTime":"2026-09-01 13:39","pubTimestamp":1788241159,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted the drug registration and marketing authorization application of Humanwell Healthcare's  unit, Yichang Humanwell Pharmaceutical, for pregabalin extended-release tablets, according to a Shanghai bourse filing on Tuesday.The drug is used to treat neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia.The pharmaceutical company invested 62 million yuan into the research and development of the drug.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK4581","BK0096","BK4588","600079","BK0188","LU0029874061.USD","LU0128526141.USD","BK0070","XBI","XLV","BK0012","LABU","BK0239","BK4137","BK0185","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339188","title":"Argenx to Highlight Autoimmune Pipeline at Key U.S. Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339188","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339188?lang=en_us&edition=fundamental","pubTime":"2026-09-01 13:38","pubTimestamp":1788241080,"startTime":"0","endTime":"0","summary":"The latest announcement is out from arGEN X ( ($GB:0QW0) ). Argenx will showcase its strategy and clinical progress to investors at two major U.S. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-to-highlight-autoimmune-pipeline-at-key-u-s-healthcare-conferences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-to-highlight-autoimmune-pipeline-at-key-u-s-healthcare-conferences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","BK4137","HCSG","XLV","LABU","BK4585","XBI","BK4588","LU0029874061.USD","SOCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838007","title":"CICC Reaffirms Their Buy Rating on Shanghai Henlius Biotech, Inc. Class H (2696)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838007?lang=en_us&edition=fundamental","pubTime":"2026-09-01 13:05","pubTimestamp":1788239149,"startTime":"0","endTime":"0","summary":"CICC analyst maintained a Buy rating on Shanghai Henlius Biotech, Inc. Class H yesterday and set a price target of HK$102.91. Currently, the analys...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cicc-reaffirms-their-buy-rating-on-shanghai-henlius-biotech-inc-class-h-2696-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cicc-reaffirms-their-buy-rating-on-shanghai-henlius-biotech-inc-class-h-2696-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388118","title":"IHH Healthcare Provides Update on Indian High Court Order on Case Involving Indian Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388118","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388118?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:30","pubTimestamp":1788237019,"startTime":"0","endTime":"0","summary":"IHH Healthcare  said the Delhi High Court has directed the appointment of a forensic auditor in relation to certain applications filed by Daiichi Sankyo  against the company's subsidiary, Fortis Healthcare , according to a Tuesday filing with the Singapore Exchange.The order mandates a factual inquiry into the dissipation of the shareholding held by Fortis' promoters, the Singh Brothers, the change in control of Fortis and the role of relevant stakeholders.The court has also directed an examination of a transaction relating to IHH's acquisition of a controlling stake in Fortis through its unit, Northern TK Venture.The court, however, has not imposed any liability, penalty or fine on the healthcare group of Fortis, with the forensic audit being termed as investigative in nature.Earlier, IHH had acquired a 31% stake in Fortis but later halted its open offer for an additional 26% stake after Daiichi had filed a contempt plea against the company's founders.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","XBI","BK4585","HCSG","Q0F.SI","BK6092","BK4581","XLV","BK6511","BK4588","LU0029874061.USD","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882201","title":"Sonic Healthcare Limited (SHL) Receives a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882201?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:15","pubTimestamp":1788228932,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst David Bailey maintained a Sell rating on Sonic Healthcare Limited today and set a price target of A$20.30. Bailey covers the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sonic-healthcare-limited-shl-receives-a-sell-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sonic-healthcare-limited-shl-receives-a-sell-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","XLV","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882258","title":"Insider Makes Bold Move With Fresh Sensus Healthcare Stock Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882258","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882258?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:07","pubTimestamp":1788228450,"startTime":"0","endTime":"0","summary":"New insider activity at Sensus Healthcare ( ($SRTS) ) has taken place on August 31, 2026. Director Eric Sachetta has demonstrated confidence in Sen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-makes-bold-move-with-fresh-sensus-healthcare-stock-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-makes-bold-move-with-fresh-sensus-healthcare-stock-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","BK4082","BK4585","BK4588","SRTS","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":16,"totalSize":370,"code":"91000000","status":"200"}]}}